Eli Lilly stock fell Thursday after the drugmaker cut its full-year profit guidance despite a first-quarter beat.
The post Eli Lilly Slumps 5% On Profit Guidance Cut Despite Mounjaro, Zepbound Beats appeared first on Investor's Business Daily.